Bi-directional effect of cholecystokinin receptor-2 overexpression on stress-triggered fear memory and anxiety in the mouse

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Chen, Qian ^a,b,d   Tang, Mingxi ^c   Mamiya, Takayoshi ^a,b   Im, Heh In ^a,e   Xiong, Xiaoli ^a   Joseph, Anu ^a,b   Tang, Ya Ping ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c SOUTHWEST MEDICAL UNIVERSITY   (China)

^d ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR 2; CORTICOTROPIN; GLUCOCORTICOID; UNCLASSIFIED DRUG; CHOLECYSTOKININ B RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BINDING AFFINITY; BIOCHEMISTRY; CONTROLLED STUDY; ENVIRONMENTAL STRESS; FEAR; FEMALE; FOREBRAIN; GENE OVEREXPRESSION; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; RECOGNITION; SPATIAL MEMORY; STRESS; TRANSGENIC MOUSE; ANIMAL; CHEMISTRY; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MEMORY; MENTAL STRESS; METABOLISM;

ANIMALIA; MUS; MUS MUSCULUS;

ADRENOCORTICOTROPIC HORMONE; AMYGDALA; ANIMALS; ANXIETY; FEAR; GLUCOCORTICOIDS; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MAZE LEARNING; MEMORY; MICE; MICE, TRANSGENIC; PROSENCEPHALON; RECEPTOR, CHOLECYSTOKININ B; STRESS, PSYCHOLOGICAL;

EID: 78651257352     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015999     Document Type: Article

References (65)

1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 617-627.
2. Rodrigues SM, Le Doux JE, Sapolsky RM (2009) The Influence of Stress Hormones on Fear Circuitry. Annu Rev Neurosci.
3. McEwen BS (2000) The neurobiology of stress: from serendipity to clinical relevance. Brain Res 886: 172-189.
4. Bereza BG, Machado M, Einarson TR (2009) Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder. Clin Ther 31: 1279-1308.
5. Packard MG (2009) Anxiety, cognition, and habit: a multiple memory systems perspective. Brain Res 1293: 121-128.
6. Lang PJ, Davis M (2006) Emotion, motivation, and the brain: reflex foundations in animal and human research. Prog Brain Res 156: 3-29.
7. LaBar KS, Cabeza R (2006) Cognitive neuroscience of emotional memory. Nat Rev Neurosci 7: 54-64.
8. Dere E, Pause BM, Pietrowsky R (2010) Emotion and episodic memory in neuropsychiatric disorders. Behav Brain Res.
9. Cornelis MC, Nugent NR, Amstadter AB, Koenen KC (2010) Genetics of posttraumatic stress disorder: review and recommendations for genome-wide association studies. Curr Psychiatry Rep 12: 313-326.
10. Yerks RM, Dodson JD (1908) The relation of strength of stimulus to rapidity of habit-formation. J Comp Neurol Psych 18: 459-482.
11. Shors TJ (2004) Learning during stressful times. Learn Mem 11: 137-144.
12. Chen Q, Nakajima A, Meacham C, Tang YP (2006) Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse. Proc Natl Acad Sci U S A 103: 3881-3886.
13. Della-Fera MA, Baile CA (1979) Cholecystokinin octapeptide: continuous picomole injections into the cerebral ventricles of sheep suppress feeding. Science 206: 471-473.
14. Rotzinger S, Lovejoy DA, Tan LA (2010) Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 31: 736-756.
15. Hill DR, Campbell NJ, Shaw TM, Woodruff GN (1987) Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists. J Neurosci 7: 2967-2976.
16. LeDoux J (2003) The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 23: 727-738.
17. Damsa C, Kosel M, Moussally J (2009) Current status of brain imaging in anxiety disorders. Curr Opin Psychiatry 22: 96-110.
18. Wettstein JG, Bueno L, Junien JL (1994) CCK antagonists: pharmacology and therapeutic interest. Pharmacol Ther 62: 267-282.
19. Wang H, Wong PT, Spiess J, Zhu YZ (2005) Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats. Neurosci Biobehav Rev 29: 1361-1373.
20. Hebb AL, Poulin JF, Roach SP, Zacharko RM, Drolet G (2005) Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Prog Neuropsychopharmacol Biol Psychiatry 29: 1225-1238.
21. Schneider R, Osterburg J, Buchner A, Pietrowsky R (2009) Effect of intranasally administered cholecystokinin on encoding of controlled and automatic memory processes. Psychopharmacology (Berl) 202: 559-567.
22. Gulpinar MA, Yegen BC (2004) The physiology of learning and memory: role of peptides and stress. Curr Protein Pept Sci 5: 457-473.
23. Handwerger K (2009) Differential patterns of HPA activity and reactivity in adult posttraumatic stress disorder and major depressive disorder. Harv Rev Psychiatry 17: 184-205.
24. Bhatnagar S, Viau V, Chu A, Soriano L, Meijer OC, et al. (2000) A cholecystokinin-mediated pathway to the paraventricular thalamus is recruited in chronically stressed rats and regulates hypothalamic-pituitary-adrenal function. J Neurosci 20: 5564-5573.
25. Sherrin T, Todorovic C, Zeyda T, Tan CH, Wong PT, et al. (2009) Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system. Mol Psychiatry 14: 291-307.
26. Hinkelmann K, Yassouridis A, Mass R, Tenge H, Kellner M, et al. (2010) CCK- 4: Psychophysiological conditioning elicits features of spontaneous panic attacks. J Psychiatr Res.
27. Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106: 274-285.
28. Scoville WB, Milner B (1957) Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry 20: 11-21.
29. Squire LR, Stark CE, Clark RE (2004) The medial temporal lobe. Annu Rev Neurosci 27: 279-306.
30. Morris RG, Anderson E, Lynch GS, Baudry M (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319: 774-776.
31. Tsien JZ, Huerta PT, Tonegawa S (1996) The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87: 1327-1338.
32. Zola-Morgan S, Squire LR, Amaral DG, Suzuki WA (1989) Lesions of perirhinal and parahippocampal cortex that spare the amygdala and hippocampal formation produce severe memory impairment. J Neurosci 9: 4355-4370.
33. Eichenbaum H, Yonelinas AR, Ranganath C (2007) The Medial Temporal Lobe and Recognition Memory. Annu Rev Neurosci.
34. Barco A, Bailey CH, Kandel ER (2006) Common molecular mechanisms in explicit and implicit memory. J Neurochem 97: 1520-1533.
35. Gass P, Fleischmann A, Hvalby O, Jensen V, Zacher C, et al. (2004) Mice with a fra-1 knock-in into the c-fos locus show impaired spatial but regular contextual learning and normal LTP. Brain Res Mol Brain Res 130: 16-22.
36. Im HI, Nakajima A, Gong B, Xiong X, Mamiya T, et al. (2009) Post-training dephosphorylation of eEF-2 promotes protein synthesis for memory consolidation. PLoS One 4: e7424.
37. Matynia A, Ng CH, Dansithong W, Chiang A, Silva AJ, et al. (2010) Muscleblind1, but not Dmpk or Six5, contributes to a complex phenotype of muscular and motivational deficits in mouse models of myotonic dystrophy. PLoS One 5: e9857.
38. Yokoyama F, Yamauchi M, Oyama M, Okuma K, Onozawa K, et al. (2009) Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic. Psychopharmacology (Berl) 205: 177-187.
39. Ma S, Morilak DA (2005) Chronic intermittent cold stress sensitises the hypothalamic-pituitary-adrenal response to a novel acute stress by enhancing noradrenergic influence in the rat paraventricular nucleus. J Neuroendocrinol 17: 761-769.
40. Bentz D, Michael T, de Quervain DJ, Wilhelm FH (2010) Enhancing exposure therapy for anxiety disorders with glucocorticoids: from basic mechanisms of emotional learning to clinical applications. J Anxiety Disord 24: 223-230.
41. Wolf OT (2009) Stress and memory in humans: twelve years of progress? Brain Res 1293: 142-154.
42. Roozendaal B, McEwen BS, Chattarji S (2009) Stress, memory and the amygdala. Nat Rev Neurosci 10: 423-433.
43. Wank SA (1995) Cholecystokinin receptors. Am J Physiol 269: G628-646.
44. Diamond DM, Park CR, Campbell AM, Woodson JC (2005) Competitive interactions between endogenous LTD and LTP in the hippocampus underlie the storage of emotional memories and stress-induced amnesia. Hippocampus 15: 1006-1025.
45. Marsch R, Foeller E, Rammes G, Bunck M, Kossl M, et al. (2007) Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J Neurosci 27: 832-839.
46. Lin CH, Lee CC, Gean PW (2003) Involvement of a calcineurin cascade in amygdala depotentiation and quenching of fear memory. Mol Pharmacol 63: 44-52.
47. Rabinowitch I, Segev I (2006) The endurance and selectivity of spatial patterns of long-term potentiation/depression in dendrites under homeostatic synaptic plasticity. J Neurosci 26: 13474-13484.
48. Chung L, Moore SD (2009) Cholecystokinin excites interneurons in rat basolateral amygdala. J Neurophysiol 102: 272-284.
49. Harro J, Lofberg C, Rehfeld JF, Oreland L (1996) Cholecystokinin peptides and receptors in the rat brain during stress. Naunyn Schmiedebergs Arch Pharmacol 354: 59-66.
50. Herman JP, Flak J, Jankord R (2008) Chronic stress plasticity in the hypothalamic paraventricular nucleus. Prog Brain Res 170: 353-364.
51. Greisen MH, Bolwig TG, Wortwein G (2005) Cholecystokinin tetrapeptide effects on HPA axis function and elevated plus maze behaviour in maternally separated and handled rats. Behav Brain Res 161: 204-212.
52. Del Bel EA, Guimaraes FS (1997) Social isolation increases cholecystokinin mRNA in the central nervous system of rats. Neuroreport 8: 3597-3600.
53. Koks S, Mannisto PT, Bourin M, Shlik J, Vasar V, et al. (2000) Cholecystokinininduced anxiety in rats: relevance of pre-experimental stress and seasonal variations. J Psychiatry Neurosci 25: 33-42.
54. Kellner M, Wiedemann K, Yassouridis A, Levengood R, Guo LS, et al. (2000) Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder. Biol Psychiatry 47: 107-111.
55. Pavlasevic S, Bednar I, Qureshi GA, Sodersten P (1993) Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety. Neuroreport 5: 225-228.
56. Farook JM, Zhu YZ, Wang H, Moochhala S, Lee L, et al. (2001) Strain differences in freezing behavior of PVG hooded and Sprague-Dawley rats: differential cortical expression of cholecystokinin2 receptors. Neuroreport 12: 2717-2720.
57. Binkley K, King N, Poonai N, Seeman P, Ulpian C, et al. (2001) Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7. J Allergy Clin Immunol 107: 887-890.
58. Kennedy JL, Bradwejn J, Koszycki D, King N, Crowe R, et al. (1999) Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 4: 284-285.
59. Tahara T, Arisawa T, Shibata T, Nakamura M, Wang F, et al. (2009) 779 TC of CCK-1 intron 1 is associated with postprandial syndrome (PDS) in Japanese male subjects. Hepatogastroenterology 56: 1245-1248.
60. Shindo S, Yoshioka N (2005) Polymorphisms of the cholecystokinin gene promoter region in suicide victims in Japan. Forensic Sci Int 150: 85-90.
61. Hattori E, Yamada K, Ebihara M, Toyota T, Nankai M, et al. (2002) Association study of the short tandem repeat in the 5' upstream region of the cholecystokinin gene with mood disorders in the Japanese population. Am J Med Genet 114: 523-526.
62. Tiwari AK, Rodgers JB, Sicard M, Zai CC, Likhodi O, et al. (2010) Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry.
63. Wang Z, Wassink T, Andreasen NC, Crowe RR (2002) Possible association of a cholecystokinin promoter variant to schizophrenia. Am J Med Genet 114: 479-482.
64. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, et al. (1999) Genetic enhancement of learning and memory in mice. Nature 401: 63-69.
65. Wood GE, Shors TJ (1998) Stress facilitates classical conditioning in males, but impairs classical conditioning in females through activational effects of ovarian hormones. Proc Natl Acad Sci U S A 95: 4066-4071.